Javascript must be enabled to continue!
Quantitative Assessment of Rectal Dose–Volume Histogram (DVH) Constraint Deviations in Image-Guided Hypofractionated Prostate Radiotherapy
View through CrossRef
Introduction: We aimed to investigate changes in rectal dose during the treatment course for prostate cancer patients treated with hypofractionated radiotherapy with daily image-guidance.
Methodology: This study included 20 prostate cancer patients treated with VMAT hypofractionated RT (60 Gy/20 Fr). IMRT- VMAT planning was performed using simulation CT images. Four patients were excluded due to inability to plan with CBCT images. Patient set-up correction shifts was used as a mesure of the daily Inter-fraction motion. The rectum was outlined on both the original treatment plan and the subsequent daily CBCT images by the same investigator. Rectal doses from the daily CT images were recalculated and compared to the original treatment plan, applying clinical acceptance criteria (V60 < 3%, V52.8 < 30%, V48.6 < 50%, and V40.8 < 60%). Rectal volume variations (V0-VX) and dose constraints were assessed for DVH compliance using post-hoc analysis and repeated measures ANOVA. Linear regression was used to evaluate the relationship between mean rectal dose constraints and rectal volume variations across all patients.
Results: Data from 16 patients with 240 daily CBCT sets were analyzed. Mean Rectal volume variation was -0.54 [- 69,76-67cc] (Figure1-A). The mean values for V60, V52.8, V48.6, and V40.8 were 2.58[0-6.15], 5.45[0-10.98], 8.47 [1.48-18.01], 11.73[4.41-23.58] and 18.69[8.69-34,91], respectively (Figure1-B). Repeated measures ANOVA analysis revealed that 7,5% (18/240), 93,75% (225/240), 14,5% (35/240), 1,25% (3/240) and 1,25% (3/240) of the subsequent treatment dose distributions did not meet our criterion of V60 < 3%, V57 <15 %, V52.8 < 30%, V48.6 < 50% and V40.8 < 60%, respectively.
The inter-fractional rectal volume variation was non-significant. (Friedman-test p=0,97). However, the variation of rectal dose constraints was significative for V57 (p=0.003), V52,8 (p=0.01) and V48.6 (p<0.0001) but not for V60 (p=0.058). The linear regression model showed a negative coefficient estimate between the mean rectal volume variation and the V57 (p<0.001) and V48.6 (p<0.001). Furthermore, a variation in rectal volume beyond 57.6 cc was significantly associated with violations of all rectal dose constraints (p < 0.001) (Table 1).The correlation between the variation in mean rectal volume and the variation in dose constraints was most significant during the fourth week of treatment (p = 0.015).
Conclusion: Image guided radiotherapy enabled compliance with rectal dose constraints in over 80% of treatment courses, meeting our clinical acceptance criteria. However, the V57 Gy constraint was not met in 93% of cases, de- spite moderate inter-fractional rectal volume variations. A toxicity evaluation is needed to assess the clinical significance of this constraint.
Title: Quantitative Assessment of Rectal Dose–Volume Histogram (DVH) Constraint Deviations in Image-Guided Hypofractionated Prostate Radiotherapy
Description:
Introduction: We aimed to investigate changes in rectal dose during the treatment course for prostate cancer patients treated with hypofractionated radiotherapy with daily image-guidance.
Methodology: This study included 20 prostate cancer patients treated with VMAT hypofractionated RT (60 Gy/20 Fr).
IMRT- VMAT planning was performed using simulation CT images.
Four patients were excluded due to inability to plan with CBCT images.
Patient set-up correction shifts was used as a mesure of the daily Inter-fraction motion.
The rectum was outlined on both the original treatment plan and the subsequent daily CBCT images by the same investigator.
Rectal doses from the daily CT images were recalculated and compared to the original treatment plan, applying clinical acceptance criteria (V60 < 3%, V52.
8 < 30%, V48.
6 < 50%, and V40.
8 < 60%).
Rectal volume variations (V0-VX) and dose constraints were assessed for DVH compliance using post-hoc analysis and repeated measures ANOVA.
Linear regression was used to evaluate the relationship between mean rectal dose constraints and rectal volume variations across all patients.
Results: Data from 16 patients with 240 daily CBCT sets were analyzed.
Mean Rectal volume variation was -0.
54 [- 69,76-67cc] (Figure1-A).
The mean values for V60, V52.
8, V48.
6, and V40.
8 were 2.
58[0-6.
15], 5.
45[0-10.
98], 8.
47 [1.
48-18.
01], 11.
73[4.
41-23.
58] and 18.
69[8.
69-34,91], respectively (Figure1-B).
Repeated measures ANOVA analysis revealed that 7,5% (18/240), 93,75% (225/240), 14,5% (35/240), 1,25% (3/240) and 1,25% (3/240) of the subsequent treatment dose distributions did not meet our criterion of V60 < 3%, V57 <15 %, V52.
8 < 30%, V48.
6 < 50% and V40.
8 < 60%, respectively.
The inter-fractional rectal volume variation was non-significant.
(Friedman-test p=0,97).
However, the variation of rectal dose constraints was significative for V57 (p=0.
003), V52,8 (p=0.
01) and V48.
6 (p<0.
0001) but not for V60 (p=0.
058).
The linear regression model showed a negative coefficient estimate between the mean rectal volume variation and the V57 (p<0.
001) and V48.
6 (p<0.
001).
Furthermore, a variation in rectal volume beyond 57.
6 cc was significantly associated with violations of all rectal dose constraints (p < 0.
001) (Table 1).
The correlation between the variation in mean rectal volume and the variation in dose constraints was most significant during the fourth week of treatment (p = 0.
015).
Conclusion: Image guided radiotherapy enabled compliance with rectal dose constraints in over 80% of treatment courses, meeting our clinical acceptance criteria.
However, the V57 Gy constraint was not met in 93% of cases, de- spite moderate inter-fractional rectal volume variations.
A toxicity evaluation is needed to assess the clinical significance of this constraint.
Related Results
Sequelae after multimodal treatment of rectal cancer
Sequelae after multimodal treatment of rectal cancer
<p dir="ltr">In recent decades, rectal cancer treatment has shifted from traditional surgical resection to include additional modalities such as radiotherapy and chemotherapy...
Sequelae after multimodal treatment of rectal cancer
Sequelae after multimodal treatment of rectal cancer
<p dir="ltr">In recent decades, rectal cancer treatment has shifted from traditional surgical resection to include additional modalities such as radiotherapy and chemotherapy...
UNCONVENTIONAL FRACTIONATION RADIOTHERAPY REGIMENS IN TREATMENT OF INOPERABLE LUNG CANCER
UNCONVENTIONAL FRACTIONATION RADIOTHERAPY REGIMENS IN TREATMENT OF INOPERABLE LUNG CANCER
The purpose of the study was to compare the efficacy and toxicity of hypofractionated versus hyperfractionated radiotherapy in patients with inoperable lung cancer.Material and Met...
The Clinical Outcome of Hypofractionated Stereotactic Radiotherapy With CyberKnife Robotic Radiosurgery for Perioptic Pituitary Adenoma
The Clinical Outcome of Hypofractionated Stereotactic Radiotherapy With CyberKnife Robotic Radiosurgery for Perioptic Pituitary Adenoma
Stereotactic radiation technique including single fraction radiosurgery and conventional fractionated stereotactic radiotherapy is widely reported as an effective treatment of pitu...
SU‐E‐T‐34: A Feasible Action Level System for DVH‐Based IMRT QA
SU‐E‐T‐34: A Feasible Action Level System for DVH‐Based IMRT QA
Purpose:Gamma‐based IMRT QA metrics have been shown to inadequately predict clinically relevant patient dose errors. In this study, we develop and evaluate an intuitive and feasibl...
Abstract 5758: Deletions of olfactomedin 4 gene is associated with progression of prostate cancer
Abstract 5758: Deletions of olfactomedin 4 gene is associated with progression of prostate cancer
Abstract
The human olfactomedin 4 gene (OLFM4) encodes an olfactomedin-related glycoprotein, which our group first cloned and characterized in myeloid cells and mapp...
Radiomic and Dosiomic Features for the Prediction of Radiation Pneumonitis Across Esophageal Cancer and Lung Cancer
Radiomic and Dosiomic Features for the Prediction of Radiation Pneumonitis Across Esophageal Cancer and Lung Cancer
PurposeThe aim was to investigate the advantages of dosiomic and radiomic features over traditional dose-volume histogram (DVH) features for predicting the development of radiation...
Clinical outcomes of hypofractionated radiotherapy (5x5 Gy) with a simultaneous integrated boost (5x6 Gy) in locally advanced rectal cancer.
Clinical outcomes of hypofractionated radiotherapy (5x5 Gy) with a simultaneous integrated boost (5x6 Gy) in locally advanced rectal cancer.
60
Background:
Hypofractionated RT (5x5 Gy) with or without subsequent chemotherapy is a standard of care used at the National Institu...

